Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Diagnosis for Conjunctivitis

By HospiMedica staff writers
Posted on 25 Jan 2006
A rapid immunochromatography test will enable differential diagnosis of acute adenoviral conjunctivitis by qualitative detection of adenoviral antigens in human eye fluid. More...


The RPS Adeno Detector, made by Rapid Pathogen Screening (South Williamsport, PA, USA), is an absorbent strip on which tear fluid is collected, which is then dipped in a buffering solution. If present, the adenoviral antigen is captured between two antigen-specific antibodies. Results are available within 10 minutes and appear as one (negative) or two (positive) red lines in the read-out area. The test is best used within seven days of developing a red eye consistent with infectious conjunctivitis.

The RPS Adeno Detector has been cleared by the U.S. Food and Drug Administration (FDA). The rapid availability of test results for differential diagnosis in point-of-care settings is expected to decrease empiric use of unnecessary antibiotics, which have been linked to risks for resistance, adverse effects, allergies, and corneal toxicity.

Unlike bacterial conjunctivitis that becomes relatively non-contagious after 48 hours of appropriate antibiotic therapy, adenoviral conjunctivitis does not improve and continues to shed a significant viral load until the eye is no longer red and tearing. Identification of conjunctivitis as of viral origin requires a longer isolation period to reduce the risk for transmission.




Related Links:
Rapid Pathogen Screening

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Preoperative Skin Preparation
BD ChloraPrep
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.